{"id":"https://openalex.org/W1971332013","doi":"https://doi.org/10.1007/bf00267943","title":"In vivo activity on murine tumors of a novel antitumor compound, N-?-dimethylaminoethyl 9-carboxy-5-hydroxy-10-methoxybenzo[a]phenazine-6-carboxamide sodium salt (NC-190)","display_name":"In vivo activity on murine tumors of a novel antitumor compound, N-?-dimethylaminoethyl 9-carboxy-5-hydroxy-10-methoxybenzo[a]phenazine-6-carboxamide sodium salt (NC-190)","publication_year":1989,"publication_date":"1989-03-01","ids":{"openalex":"https://openalex.org/W1971332013","doi":"https://doi.org/10.1007/bf00267943","mag":"1971332013","pmid":"https://pubmed.ncbi.nlm.nih.gov/2924370"},"language":"en","primary_location":{"id":"doi:10.1007/bf00267943","doi":"https://doi.org/10.1007/bf00267943","is_oa":false,"landing_page_url":"https://doi.org/10.1007/bf00267943","pdf_url":null,"source":{"id":"https://openalex.org/S117498271","display_name":"Cancer Chemotherapy and Pharmacology","issn_l":"0344-5704","issn":["0344-5704","1432-0843"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Chemotherapy and Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5002265537","display_name":"Shiro Nakaike","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I144245601","display_name":"Taisho Pharmaceutical (Japan)","ror":"https://ror.org/033nw2736","country_code":"JP","type":"company","lineage":["https://openalex.org/I144245601"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Shiro Nakaike","raw_affiliation_strings":["Research Center, Taisho Pharm. Co., Ltd., Saitama, Japan","Research Center, Taisho Pharm. Co., Ltd., Ohmiya-shi, Saitama, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Center, Taisho Pharm. Co., Ltd., Saitama, Japan","institution_ids":["https://openalex.org/I144245601"]},{"raw_affiliation_string":"Research Center, Taisho Pharm. Co., Ltd., Ohmiya-shi, Saitama, Japan","institution_ids":["https://openalex.org/I144245601"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Takehiro Yamagishi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I144245601","display_name":"Taisho Pharmaceutical (Japan)","ror":"https://ror.org/033nw2736","country_code":"JP","type":"company","lineage":["https://openalex.org/I144245601"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Takehiro Yamagishi","raw_affiliation_strings":["Research Center, Taisho Pharm. Co., Ltd., 1-403, Yoshino-cho, 330, Ohmiya-shi, Saitama, Japan","Research Center, Taisho Pharm. Co., Ltd., Ohmiya-shi, Saitama, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Center, Taisho Pharm. Co., Ltd., 1-403, Yoshino-cho, 330, Ohmiya-shi, Saitama, Japan","institution_ids":["https://openalex.org/I144245601"]},{"raw_affiliation_string":"Research Center, Taisho Pharm. Co., Ltd., Ohmiya-shi, Saitama, Japan","institution_ids":["https://openalex.org/I144245601"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020105653","display_name":"Kazunori Samata","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I144245601","display_name":"Taisho Pharmaceutical (Japan)","ror":"https://ror.org/033nw2736","country_code":"JP","type":"company","lineage":["https://openalex.org/I144245601"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Kazunori Samata","raw_affiliation_strings":["Research Center, Taisho Pharm. Co., Ltd., 1-403, Yoshino-cho, 330, Ohmiya-shi, Saitama, Japan","Research Center, Taisho Pharm. Co., Ltd., Ohmiya-shi, Saitama, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Center, Taisho Pharm. Co., Ltd., 1-403, Yoshino-cho, 330, Ohmiya-shi, Saitama, Japan","institution_ids":["https://openalex.org/I144245601"]},{"raw_affiliation_string":"Research Center, Taisho Pharm. Co., Ltd., Ohmiya-shi, Saitama, Japan","institution_ids":["https://openalex.org/I144245601"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Keiko Nishida","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I144245601","display_name":"Taisho Pharmaceutical (Japan)","ror":"https://ror.org/033nw2736","country_code":"JP","type":"company","lineage":["https://openalex.org/I144245601"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Keiko Nishida","raw_affiliation_strings":["Research Center, Taisho Pharm. Co., Ltd., 1-403, Yoshino-cho, 330, Ohmiya-shi, Saitama, Japan","Research Center, Taisho Pharm. Co., Ltd., Ohmiya-shi, Saitama, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Center, Taisho Pharm. Co., Ltd., 1-403, Yoshino-cho, 330, Ohmiya-shi, Saitama, Japan","institution_ids":["https://openalex.org/I144245601"]},{"raw_affiliation_string":"Research Center, Taisho Pharm. Co., Ltd., Ohmiya-shi, Saitama, Japan","institution_ids":["https://openalex.org/I144245601"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006182343","display_name":"Kouko Inazuki","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I144245601","display_name":"Taisho Pharmaceutical (Japan)","ror":"https://ror.org/033nw2736","country_code":"JP","type":"company","lineage":["https://openalex.org/I144245601"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Kouko Inazuki","raw_affiliation_strings":["Research Center, Taisho Pharm. Co., Ltd., 1-403, Yoshino-cho, 330, Ohmiya-shi, Saitama, Japan","Research Center, Taisho Pharm. Co., Ltd., Ohmiya-shi, Saitama, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Center, Taisho Pharm. Co., Ltd., 1-403, Yoshino-cho, 330, Ohmiya-shi, Saitama, Japan","institution_ids":["https://openalex.org/I144245601"]},{"raw_affiliation_string":"Research Center, Taisho Pharm. Co., Ltd., Ohmiya-shi, Saitama, Japan","institution_ids":["https://openalex.org/I144245601"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113720163","display_name":"Tomoko Ichihara","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I144245601","display_name":"Taisho Pharmaceutical (Japan)","ror":"https://ror.org/033nw2736","country_code":"JP","type":"company","lineage":["https://openalex.org/I144245601"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Tomoko Ichihara","raw_affiliation_strings":["Research Center, Taisho Pharm. Co., Ltd., 1-403, Yoshino-cho, 330, Ohmiya-shi, Saitama, Japan","Research Center, Taisho Pharm. Co., Ltd., Ohmiya-shi, Saitama, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Center, Taisho Pharm. Co., Ltd., 1-403, Yoshino-cho, 330, Ohmiya-shi, Saitama, Japan","institution_ids":["https://openalex.org/I144245601"]},{"raw_affiliation_string":"Research Center, Taisho Pharm. Co., Ltd., Ohmiya-shi, Saitama, Japan","institution_ids":["https://openalex.org/I144245601"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048420434","display_name":"Yoshihiro Migita","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I144245601","display_name":"Taisho Pharmaceutical (Japan)","ror":"https://ror.org/033nw2736","country_code":"JP","type":"company","lineage":["https://openalex.org/I144245601"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yoshihiro Migita","raw_affiliation_strings":["Research Center, Taisho Pharm. Co., Ltd., 1-403, Yoshino-cho, 330, Ohmiya-shi, Saitama, Japan","Research Center, Taisho Pharm. Co., Ltd., Ohmiya-shi, Saitama, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Center, Taisho Pharm. Co., Ltd., 1-403, Yoshino-cho, 330, Ohmiya-shi, Saitama, Japan","institution_ids":["https://openalex.org/I144245601"]},{"raw_affiliation_string":"Research Center, Taisho Pharm. Co., Ltd., Ohmiya-shi, Saitama, Japan","institution_ids":["https://openalex.org/I144245601"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113754408","display_name":"Susumu Otomo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I144245601","display_name":"Taisho Pharmaceutical (Japan)","ror":"https://ror.org/033nw2736","country_code":"JP","type":"company","lineage":["https://openalex.org/I144245601"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Susumu Otomo","raw_affiliation_strings":["Research Center, Taisho Pharm. Co., Ltd., 1-403, Yoshino-cho, 330, Ohmiya-shi, Saitama, Japan","Research Center, Taisho Pharm. Co., Ltd., Ohmiya-shi, Saitama, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Center, Taisho Pharm. Co., Ltd., 1-403, Yoshino-cho, 330, Ohmiya-shi, Saitama, Japan","institution_ids":["https://openalex.org/I144245601"]},{"raw_affiliation_string":"Research Center, Taisho Pharm. Co., Ltd., Ohmiya-shi, Saitama, Japan","institution_ids":["https://openalex.org/I144245601"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111532471","display_name":"Hironaka Aihara","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I144245601","display_name":"Taisho Pharmaceutical (Japan)","ror":"https://ror.org/033nw2736","country_code":"JP","type":"company","lineage":["https://openalex.org/I144245601"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hironaka Aihara","raw_affiliation_strings":["Research Center, Taisho Pharm. Co., Ltd., 1-403, Yoshino-cho, 330, Ohmiya-shi, Saitama, Japan","Research Center, Taisho Pharm. Co., Ltd., Ohmiya-shi, Saitama, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Center, Taisho Pharm. Co., Ltd., 1-403, Yoshino-cho, 330, Ohmiya-shi, Saitama, Japan","institution_ids":["https://openalex.org/I144245601"]},{"raw_affiliation_string":"Research Center, Taisho Pharm. Co., Ltd., Ohmiya-shi, Saitama, Japan","institution_ids":["https://openalex.org/I144245601"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5033562835","display_name":"Shigeru Tsukagoshi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I42570316","display_name":"Japanese Foundation For Cancer Research","ror":"https://ror.org/00bv64a69","country_code":"JP","type":"nonprofit","lineage":["https://openalex.org/I42570316"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Shigeru Tsukagoshi","raw_affiliation_strings":["Cancer Chemotherapy Center, Cancer Institute, Japanese Foundation for Cancer Research, 1-37-1, Kami-Ikebukuro, Toshima-ku, 170, Tokyo, Japan","Cancer Chemotherapy Center, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Chemotherapy Center, Cancer Institute, Japanese Foundation for Cancer Research, 1-37-1, Kami-Ikebukuro, Toshima-ku, 170, Tokyo, Japan","institution_ids":["https://openalex.org/I42570316"]},{"raw_affiliation_string":"Cancer Chemotherapy Center, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan","institution_ids":["https://openalex.org/I42570316"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4390,"currency":"USD","value_usd":4390},"apc_paid":null,"fwci":1.8855,"has_fulltext":false,"cited_by_count":15,"citation_normalized_percentile":{"value":0.82390382,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"23","issue":"3","first_page":"135","last_page":"9"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12356","display_name":"Bioactive Compounds and Antitumor Agents","score":0.6934000253677368,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12356","display_name":"Bioactive Compounds and Antitumor Agents","score":0.6934000253677368,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.1103999987244606,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13454","display_name":"Phenothiazines and Benzothiazines Synthesis and Activities","score":0.04179999977350235,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/anticancer-activity","display_name":"anticancer activity","score":0.8569999933242798},{"id":"https://openalex.org/keywords/mouse-tumor-model","display_name":"mouse tumor model","score":0.7250000238418579},{"id":"https://openalex.org/keywords/p388-leukemia","display_name":"P388 leukemia","score":0.9580000042915344},{"id":"https://openalex.org/keywords/l1210-cells","display_name":"L1210 leukemia","score":0.9980000257492065},{"id":"https://openalex.org/keywords/b16-melanoma","display_name":"B16 melanoma","score":0.9950000047683716},{"id":"https://openalex.org/keywords/reticulum-cell-sarcoma","display_name":"reticulum cell sarcoma","score":0.953000009059906},{"id":"https://openalex.org/keywords/sarcoma-180","display_name":"sarcoma 180","score":0.9990000128746033},{"id":"https://openalex.org/keywords/hepatocellular-carcinoma","display_name":"hepatocellular carcinoma","score":0.8230000138282776},{"id":"https://openalex.org/keywords/ascites-hepatoma","display_name":"ascites hepatoma","score":0.8090000152587891},{"id":"https://openalex.org/keywords/in-vivo-antitumor-activity","display_name":"in vivo antitumor activity","score":0.4480000138282776},{"id":"https://openalex.org/keywords/structure-activity-relationship","display_name":"structure-activity relationship","score":0.625}],"concepts":[{"id":"https://openalex.org/C2778256501","wikidata":"https://www.wikidata.org/wiki/Q223911","display_name":"Sarcoma","level":2,"score":0.7094439268112183},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.6100544929504395},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.460183709859848},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.456484317779541},{"id":"https://openalex.org/C2777928079","wikidata":"https://www.wikidata.org/wiki/Q2677027","display_name":"Rat\u00f3n","level":2,"score":0.42295870184898376},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.411480575799942},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3854779005050659},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.33670732378959656},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3027402460575104},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.27391570806503296},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.22002246975898743},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.18336325883865356},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007941","descriptor_name":"Leukemia P388","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000556","qualifier_name":"secondary","is_major_topic":false},{"descriptor_ui":"D008807","descriptor_name":"Mice, Inbred BALB C","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008811","descriptor_name":"Mice, Inbred DBA","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009374","descriptor_name":"Neoplasms, Experimental","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D010619","descriptor_name":"Phenazines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1007/bf00267943","doi":"https://doi.org/10.1007/bf00267943","is_oa":false,"landing_page_url":"https://doi.org/10.1007/bf00267943","pdf_url":null,"source":{"id":"https://openalex.org/S117498271","display_name":"Cancer Chemotherapy and Pharmacology","issn_l":"0344-5704","issn":["0344-5704","1432-0843"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Chemotherapy and Pharmacology","raw_type":"journal-article"},{"id":"pmid:2924370","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2924370","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer chemotherapy and pharmacology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9476000070571899,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":7,"referenced_works":["https://openalex.org/W132042431","https://openalex.org/W1977226572","https://openalex.org/W1998495461","https://openalex.org/W2117668915","https://openalex.org/W2399084095","https://openalex.org/W2434793886","https://openalex.org/W3212824139"],"related_works":["https://openalex.org/W1991843596","https://openalex.org/W1992092714","https://openalex.org/W2419372807","https://openalex.org/W2019118602","https://openalex.org/W2049545781","https://openalex.org/W2322308976","https://openalex.org/W1728017740","https://openalex.org/W1602091957","https://openalex.org/W1901113025","https://openalex.org/W2409606808"],"abstract_inverted_index":null,"counts_by_year":[{"year":2022,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}